2015 – Nummer 2 | OnkoNytt | Page 3
Gabor Liposits (@G_LipositsMD) | Twitter
Gabor Liposits (@G_LipositsMD) | Twitter
Geriatric oncology: the time is now - ecancer
Young SIOG Leadership | SIOG
Fabio GOMES | Clinical Research Fellow | MD MRes | The Christie NHS Foundation Trust, Manchester | Medical Oncology
Gabor Liposits on Twitter: "Excellent presentation by @DrR_DUNNE on malnutrition at the Young SIOG poster walk. Great job by @MelissaLoh21 @rochgerionc Congratulations!! #YoungSIOG #SIOG2018… https://t.co/NA3go8hN8P"
Gabor Liposits, Physician at Helse møre og romsdal, molde hospital
Tilbyr enda bedre kreftbehandling - rbnett.no - nyheter, sport, kultur og økonomi
Media Tweets by Gabor Liposits (@G_LipositsMD) | Twitter
Gabor Liposits on Twitter: "Save the date!!!!… "
Europæisk kræftorganisation udsteder særligt certifikat til Hospitalsenheden Vest
Gabor Liposits в Twitter: "ESMO's official decision support system the ONCOassist app included G8 screening tool. Important step forward getting more recognition for #gerionc. Get it today! It is free! @YoungSIOG @SIOGorg @
Gabor Liposits (@G_LipositsMD) | Twitter
Olaparib treatment in older patients with ovarian cancer: need for 'real-world' data beyond clinical trials - ecancer
ESMOExaminationResults2015
Nicolò BATTISTI | Clinical Research Fellow in Medical Oncology - Specialty Doctor | The Royal Marsden NHS Foundation Trust, London | Department of Medicine - Breast Unit
Kommentar: ECOG funkjonsstatus – begrenset klinisk verdi hos eldre kreftpasienter | OnkoNytt
OncoAlert - https://www.geriatriconcology.net/article/S1879... | Facebook
PDF) Use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in older patients with ER-positive HER2-negative breast cancer: Young International Society of Geriatric Oncology review paper
Young SIOG Leadership | SIOG
Gábor Liposits (lipositsg) on Pinterest
Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients wit
